Results

eNauka >  Rezultati >  Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: interim safety and efficacy results from the Phase 3 EVOLVE-MS-1 Study
Naziv Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: interim safety and efficacy results from the Phase 3 EVOLVE-MS-1 Study
Autori: Singer, Barry A.; Drulović, Jelena S. ; Chen, Hailu; Lyons, Jennifer; Then, Bergh F.; Negroski, Donald; Kapadia, Sunil
Godina: 2021
Publikacija: Multiple sclerosis journal (37th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Oct 13-15, 2021)
ISSN: 1352-4585 Multiple Sclerosis Pretraži identifikator
Izdavač: London : SAGE Publications
Tip rezultata: Konferencijski rad
Kolacija: vol. 27 br. Suppl 2 str. 619-620
WoS-ID: 000706771302115
URI: https://enauka.gov.rs/handle/123456789/827906
URL: https://journals.sagepub.com/doi/epub/10.1177/13524585211044667
Projekat: Biogen
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
Mp kategorija će biti prikazana naknadno.

Find the DOI


Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.